Browse by Audience
Skip to content
Papers of the Week
Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect.
Abstract
Some studies have indicated that a local injection of Botulinum Toxin Type A (BTX-A) is a promising therapy for trigeminal neuralgia (TN). However, BTX-A treatment is still ineffective for approximately 10-43% of patients. We therefore investigated which factors are associated with the therapeutic effect in BTX-A treatment of medically refractory, classical TN.